David C. Sachs - 31 Dec 2025 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Role
Chief Financial Officer
Signature
/s/ Philip LoScalzo, as Attorney-in-Fact
Issuer symbol
IBRX
Transactions as of
31 Dec 2025
Net transactions value
-$30,561
Form type
4
Filing time
05 Jan 2026, 18:11:44 UTC
Previous filing
25 Feb 2025
Next filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sachs David C. Chief Financial Officer C/O IMMUNITYBIO, INC., 3530 JOHN HOPKINS COURT, SAN DIEGO /s/ Philip LoScalzo, as Attorney-in-Fact 05 Jan 2026 0001848899

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBRX Common Stock Options Exercise $0 +30,397 +13% $0.000000 256,017 31 Dec 2025 Direct F1
transaction IBRX Common Stock Tax liability $30,561 -15,435 -6% $1.98 240,582 31 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBRX Restricted Stock Units Options Exercise $0 -30,397 -40% $0.000000 45,602 31 Dec 2025 Common Stock 30,397 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
F2 On December 31, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2025 was the settlement price used to calculate the shares withheld.
F3 17,242 of the RSUs vested on December 9, 2021. Five percent (5%) of the remaining 151,989 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026.

Remarks:

Exhibit 24 - Power of Attorney